Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 2, 2026 21:29 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 5,000 | $61.21 | $306,050.00 |
DisclosureSEC source: 0001061983-26-000014 · form4.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,933 Read SEC document |
| March 02, 2026 Filed Mar 2, 2026 21:28 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 886 | $0.00 Strike: $37.63 | $0.00 |
DisclosureSEC source: 0001061983-26-000013 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 886 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| March 02, 2026 Filed Mar 2, 2026 21:28 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 886 | $61.62 | $54,595.32 |
DisclosureSEC source: 0001061983-26-000013 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,440 Read SEC document |
| March 02, 2026 Filed Mar 2, 2026 21:28 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 886 | $37.63 | $33,340.18 |
DisclosureSEC source: 0001061983-26-000013 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 01:17 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.26 | $0.00 |
DisclosureSEC source: 0001061983-26-000012 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 15,000 shares Expires 2031-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 01:17 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 15,000 | $61.93 | $928,950.00 |
DisclosureSEC source: 0001061983-26-000012 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,440 Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 01:17 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 15,000 | $23.26 | $348,900.00 |
DisclosureSEC source: 0001061983-26-000012 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2026 Filed Feb 2, 2026 21:40 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 886 | $0.00 Strike: $37.63 | $0.00 |
DisclosureSEC source: 0001061983-26-000011 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 886 Underlying: Common Stock · 886 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 02, 2026 Filed Feb 2, 2026 21:40 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 886 | $62.10 | $55,020.60 |
DisclosureSEC source: 0001061983-26-000011 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,440 Read SEC document |
| February 02, 2026 Filed Feb 2, 2026 21:40 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 886 | $37.63 | $33,340.18 |
DisclosureSEC source: 0001061983-26-000011 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:22 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 98 | $63.44 | $6,217.12 |
DisclosureSEC source: 0001061983-26-000008 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,971 F1 · kind: Fully vested shares of common stock received in lieu of cash retainer pursuant to Equity in Lieu of Cash Retainer Option available to members of our Board of Directors. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:20 UTC |
WIERENGA WENDELLDirector
|
GrantCommon Stock | 98 | $63.44 | $6,217.12 |
DisclosureSEC source: 0001061983-26-000007 · form4.xml · nonDerivative · entry 1 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,542 F1 · kind: Fully vested shares of common stock received in lieu of cash retainer pursuant to Equity in Lieu of Cash Retainer Option available to members of our Board of Directors. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:18 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 197 | $63.44 | $12,497.68 |
DisclosureSEC source: 0001061983-26-000006 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,174 F1 · kind: Fully vested shares of common stock received in lieu of cash retainer pursuant to Equity in Lieu of Cash Retainer Option available to members of our Board of Directors. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:17 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 334 | $63.44 | $21,188.96 |
DisclosureSEC source: 0001061983-26-000005 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,912 F1 · kind: Fully vested shares of common stock received in lieu of cash retainer pursuant to Equity in Lieu of Cash Retainer Option available to members of our Board of Directors. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:15 UTC |
Harrington Robert ArthurDirector
|
GrantCommon Stock | 197 | $63.44 | $12,497.68 |
DisclosureSEC source: 0001061983-26-000004 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,739 F1 · kind: Fully vested shares of common stock received in lieu of cash retainer pursuant to Equity in Lieu of Cash Retainer Option available to members of our Board of Directors. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:17 UTC |
Daly James MDirector
|
GrantCommon Stock | 197 | $63.44 | $12,497.68 |
DisclosureSEC source: 0001061983-26-000010 · form4.xml · nonDerivative · entry 1 Daly James M · CIK 0001560782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197 F1 · kind: Fully vested shares of common stock received in lieu of cash retainer pursuant to Equity in Lieu of Cash Retainer Option available to members of Issuer's Board of Directors. Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:26 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.26 | $0.00 |
DisclosureSEC source: 0001061983-26-000002 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 15,000 shares Expires 2031-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:26 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 15,000 | $60.28 | $904,200.00 |
DisclosureSEC source: 0001061983-26-000002 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,440 Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:26 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 15,000 | $23.26 | $348,900.00 |
DisclosureSEC source: 0001061983-26-000002 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:01 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 885 | $0.00 Strike: $37.63 | $0.00 |
DisclosureSEC source: 0001061983-26-000001 · form4.xml · derivative · entry 4 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,772 Underlying: Common Stock · 885 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:01 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 885 | $63.16 | $55,896.60 |
DisclosureSEC source: 0001061983-26-000001 · form4.xml · nonDerivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,440 Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:01 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 885 | $37.63 | $33,302.55 |
DisclosureSEC source: 0001061983-26-000001 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:01 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 913 | $62.09 | $56,688.17 |
DisclosureSEC source: 0001061983-26-000001 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,440 Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:34 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,809 | $62.44 | $112,953.96 |
DisclosureSEC source: 0001061983-25-000057 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,353 Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 16,506 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · derivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,506 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 54,727 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · derivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,727 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 16,506 | $6.67 | $110,095.02 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Cash exercise and hold transaction. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC |
Blum Robert IDirector · President & CEO
|
Tax withholdingCommon Stock | 30,426 | $68.18 | $2,074,444.68 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,503 F2 · kind: Shares represent withholding of shares to cover exercise price and tax withholding obligations resulting from the net share settlement of 54,727 non-qualified stock options. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 54,727 | $6.67 | $365,029.09 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Net share settlement transaction. Not a market transaction. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:13 UTC |
WIERENGA WENDELLDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001061983-25-000051 · form4.xml · derivative · entry 3 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:13 UTC |
WIERENGA WENDELLDirector
|
SaleCommon Stock | 20,000 | $66.14 | $1,322,800.00 |
DisclosureSEC source: 0001061983-25-000051 · form4.xml · nonDerivative · entry 2 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,444 Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:13 UTC |
WIERENGA WENDELLDirector
|
Exercise / conversionCommon Stock | 20,000 | $7.61 | $152,200.00 |
DisclosureSEC source: 0001061983-25-000051 · form4.xml · nonDerivative · entry 1 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:03 UTC |
Lee SungEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 805 | $62.72 | $50,489.60 |
DisclosureSEC source: 0001061983-25-000053 · form4.xml · nonDerivative · entry 3 Lee Sung · CIK 0001793200 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,416 F3 · kind: Shares withheld for tax withholding upon vesting of performance shares. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:03 UTC |
Lee SungEVP, Chief Financial Officer
|
GrantCommon Stock | 2,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000053 · form4.xml · nonDerivative · entry 2 Lee Sung · CIK 0001793200 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,221 F2 · kind: Performance shares earned upon achievement of performance goal. Shares vested immediately. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:03 UTC |
Lee SungEVP, Chief Financial Officer
|
GrantCommon Stock | 2,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000053 · form4.xml · nonDerivative · entry 1 Lee Sung · CIK 0001793200 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,069 F1 · kind: Performance shares earned upon achievement of performance goal. Shares remain subject to 1-year time vesting requirement. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:09 UTC |
Blum Robert IDirector · President & CEO
|
Tax withholdingCommon Stock | 2,935 | $62.72 | $184,083.20 |
DisclosureSEC source: 0001061983-25-000056 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,604 F3 · kind: Withholding of shares for tax on performance shares that have been earned and vested. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:09 UTC |
Blum Robert IDirector · President & CEO
|
GrantCommon Stock | 5,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000056 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,539 F2 · kind: Performance Stock Units earned upon achieving performance goal. Shares have been vested. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:09 UTC |
Blum Robert IDirector · President & CEO
|
GrantCommon Stock | 5,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000056 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,774 F1 · kind: Performance shares earned as a result of achieving performance goal. Shares remain subject to 1-year time vesting requirement. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:06 UTC |
Malik Fady IbrahamEVP Research & Development
|
Tax withholdingCommon Stock | 1,016 | $62.72 | $63,723.52 |
DisclosureSEC source: 0001061983-25-000055 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,536 F3 · kind: Withholding of shares for tax withholding on vesting of performance shares. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:06 UTC |
Malik Fady IbrahamEVP Research & Development
|
GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000055 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,552 F2 · kind: Performance shares earned upon achieving performance goal. Shares vested immediately. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:06 UTC |
Malik Fady IbrahamEVP Research & Development
|
GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000055 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,552 F1 · kind: Performance shares earned upon achieving performance goal. Shares remain subject to 1-year time vesting requirement. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:04 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 675 | $62.72 | $42,336.00 |
DisclosureSEC source: 0001061983-25-000054 · form4.xml · nonDerivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,162 F3 · kind: Withholding of shares for tax withholding on vesting of performance shares. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:04 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
GrantCommon Stock | 1,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000054 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,837 F2 · kind: Performance shares earned upon achievement of performance goal. Shares remain subject to 1-year vesting requirement. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:04 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
GrantCommon Stock | 1,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000054 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,249 F1 · kind: Performance shares earned upon achieving performance goal. Shares vested immediately. Read SEC document |
| December 16, 2025 Filed Dec 16, 2025 21:29 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 2,200 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-25-000050 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,200 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2025 Filed Dec 16, 2025 21:29 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,200 | $61.24 | $134,728.00 |
DisclosureSEC source: 0001061983-25-000050 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,552 Read SEC document |
| December 16, 2025 Filed Dec 16, 2025 21:29 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,200 | $10.60 | $23,320.00 |
DisclosureSEC source: 0001061983-25-000050 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 22:28 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 1,042 | $0.00 Strike: $39.13 | $0.00 |
DisclosureSEC source: 0001061983-25-000049 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,403 Underlying: Common Stock · 1,042 shares Expires 2033-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 22:28 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,042 | $65.96 | $68,730.32 |
DisclosureSEC source: 0001061983-25-000049 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,660 Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 22:28 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,042 | $39.13 | $40,773.46 |
DisclosureSEC source: 0001061983-25-000049 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.